Cargando…

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes

Detalles Bibliográficos
Autores principales:	Svane, I, Andersen, R, Donia, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072296/ http://dx.doi.org/10.1186/2051-1426-2-S2-I14

Ejemplares similares

S47. Tumour infiltrating lymphocytes - a predictive marker?
por: Galon, J
Publicado: (2014)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
por: Andersen, Rikke, et al.
Publicado: (2014)

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
por: Ellebaek, Eva, et al.
Publicado: (2012)

S2. Therapeutic strategies based on overcoming immune resistance mechanisms within the melanoma tumour microenvironment
por: Gajewski, T
Publicado: (2014)

S6. Proffered paper: Anti-tumour immunomodulatory activity of heat shock protein Hsp70 in therapy of malignant brain tumours: preclinical and clinical data
por: Shevtsov, M, et al.
Publicado: (2014)

Polyfunctional incompletely differentiated CD8+ T cells accumulates after adoptive transfer of tumor-infiltrating lymphocytes and establish immunological memory in patients with metastatic melanoma
por: Donia, Marco, et al.
Publicado: (2015)

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
por: Grassmann, S, et al.
Publicado: (2014)

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
por: Bjørn, Jon, et al.
Publicado: (2013)

S79. CAR strategies in solid tumours
por: Rossig, C
Publicado: (2014)

S38. Many reasons for combining immunotherapy with chemotherapy to enhance anti tumour response
por: Dalgleish, A, et al.
Publicado: (2014)

S78. Proffered paper: High-affinity CD20-specific TCRs suitable for adoptive immunotherapy can be readily isolated from the allo-repertoire using reverse immunology
por: Jahn, L, et al.
Publicado: (2014)

IL-12 superfamily members guiding the function of Rorγt-dependent innate lymphocytes
por: Becher, Burkhard
Publicado: (2012)

S50. Proffered paper: Complex tumour microenvironment screening platform captures biological responses of cancer therapeutics
por: Layman, H, et al.
Publicado: (2014)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

Lighting a candle in the dark: advances in the genetics and (gene) therapy of retinal dystrophies
por: den Hollander, Anneke I
Publicado: (2012)

Post-entry events of efficient R5 vs. inefficient X4 HIV-1 replication in primary CD4(+)T lymphocytes, a transcriptome analysis
por: Mariani, Samanta A, et al.
Publicado: (2009)

PReS13-SPK-1586: Biological agents for the treatment of rheumatic diseases: present and future targets of biologic therapy
por: Mcinnes, I
Publicado: (2013)

Is there a role for cytokine-immune based therapy in HIV disease therapy?
por: Poli, Guido
Publicado: (2010)

Statistical issues in the analysis of non-pharmacological therapy trials with clustering by care-provider or therapy group
por: Roberts, Chris
Publicado: (2011)

Universal access to anti-HIV therapy
por: Souteyrand, Yves
Publicado: (2012)

Gene therapy to cure HIV? Prospects and realities
por: Hütter, Gero
Publicado: (2012)

Molecular approach to food allergy diagnosis and therapy
por: van Ree, Ronald
Publicado: (2011)

Hypoxia and tumour angiogenesis involved in breast cancer progression and targets for therapy
por: Harris, AL
Publicado: (2000)

PReS13-SPK-1129: Biologic therapies in SLE
por: Isenberg, DA
Publicado: (2013)

Advances in adoptive cellular therapy of cancer
por: Stroncek, David
Publicado: (2015)

Novel vaccine and gene therapy approaches against HIV-AIDS
por: Das, A, et al.
Publicado: (2009)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

PReS13-SPK-1572: The therapy management of pain amplification syndrome
por: Maillard, S
Publicado: (2013)

Mining data from 1000 genomes to identify the causal variant in regions under positive selection
por: Grossman, Shari, et al.
Publicado: (2010)

Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations
por: Lionetto, Luana, et al.
Publicado: (2015)

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
por: Sharma, P
Publicado: (2014)

Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome
por: Van den Steen, Philippe E, et al.
Publicado: (2010)

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes
por: Donia, Marco, et al.
Publicado: (2012)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

Role of signal transduction and microRNAs on the immunogenicity of melanoma cells
por: Meyer, Stefanie, et al.
Publicado: (2015)

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial
por: Schmoll, H, et al.
Publicado: (2014)

PReS13-SPK-1247: Activity and damage in juvenile systemic sclerosis- we have to measure them
por: Foeldvari, I
Publicado: (2013)

PReS13-SPK-1321: Expanding clinical spectrum of autoinflammatory diseases
por: Aksentijevich, I
Publicado: (2013)

S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Cojocaru, G, et al.
Publicado: (2014)

Immunological and virological aspects of HIV cell-to-cell transfer
por: Schwartz, Olivier
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6fbrk6oial23na21ofe8i50m0g